-
Over-the-counter contraceptive products that contain the spermicide nonoxynol-9 (N-9) now will carry a warning label to alert consumers that such products do not protect against sexually transmitted diseases (STDs) and HIV/AIDS, following a final ruling by the FDA.
-
AIDS Healthcare Foundation (AHF) of Los Angeles, CA, recently raised a stir when the organization's president and its medical chief announced that it was time for the federal government to stop funding research for the HIV vaccine and to put that money into prevention and treatment that works.
-
-
A Washington, DC, HIV prevention intervention targets a population of mostly African-American women who come from such abusive backgrounds that their risky behaviors even place their children at risk of mother-to-child (MTC) transmission.
-
Vernakalant is a new investigational anti- arrhythmic drug. The compound is relatively selective, blocking the early-activating potassium channel and the frequency-dependent sodium channel.
-
Dowson and colleagues performed a randomized, controlled trial to assess the efficacy of PFO closure in reducing the incidence of migraine with aura.
-
-
-
FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions.
-
Setoguchi and colleagues assessed the degree of utilization of guideline (Class I) protective drugs in elderly patients who survived an acute MI (AMI) and at least 30 days thereafter.
